您当前所在的位置:首页 > 产品中心 > 产品信息
Captopril_分子结构_CAS_62571-86-2)
点击图片或这里关闭

Captopril

产品号 Bio-0622 公司名称 InterBioScreen
CAS号 62571-86-2 公司网站 http://www.ibscreen.com
分子式 C9H15NO3S 电 话 +7 49652 40091
分子量 217.2853 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 1067

产品价格信息

请登录

产品别名

标题
Captopril
IUPAC标准名
(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
IUPAC传统名
(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
别名
Capoten
Capace
Acenorm
Acepril

产品登记号

CAS号 62571-86-2

产品性质

应用领域 Exp. drug for treatment of myocardial infarction
应用领域 Smooth muscle relaxant
简要说明 Diastereomers
应用领域 Antihypertensive agent
应用领域 Drug used for diagnosis and treatment of renin-dependent hypertension
生物活性机理 ACE inhibitor
生物活性机理 May inhibit local angiotensin 2 at vascular and renal sites so attenuating catecholamine release
生物活性机理 May increase prostaglandin synthesis
生物活性机理 Increases urinary excretion of PGE2
生物活性机理 increases plasma-renin activity resulting from loss of negative feedback on renin release due to reduced angiotensin-2 concentration
生物活性机理 increases plasma levels of PGE2 and PGE2-alpha metabolites.
生物活性机理 increased sodium-excretion
生物活性机理 increased plasma-renin causes decrease in aldosterone-secretion resulting in: small increases in serum-potassium
生物活性机理 decreases plasma-angiotensin-2 concentration
生物活性机理 decrease in plasma-volume
生物活性机理 apparent primary action involves suppression of the renin-angiotensin-aldosterone-system
生物活性机理 angiotensin-antagonist

产品详细信息

参考文献

  • Ger. Pat., 1977, Squibb, 2 703 828; CA, 88, 7376c, (synth)
  • Ondetti, M.A. et al., Science (Washington, D.C.), 1977, 196, 441, (use)
  • Cardoni, A.A. et al., Drug Intell. Clin. Pharm., 1981, 15, 932, (pharmacol, rev)
  • Horovitz, Z.P. et al., Pharmacol. Biochem. Prop. Drug Subst., 1981, 3, 148, (pharmacol)
  • Kadin, H., Anal. Profiles Drug Subst., 1982, 11, 79, (synth, prop, detn, pharmacol, rev)
  • Shimazaki, M. et al., Chem. Pharm. Bull., 1982, 30, 3139, (synth)
  • Condon, M.E. et al., J. Med. Chem., 1982, 25, 250, (synth)
  • Migdalof, B.H. et al., Drug Metab. Rev., 1984, 15, 841, (rev)
  • Aboul-Enein, H.Y. et al., Spectrosc. Lett., 1985, 18, 419, (pmr, conformn)
  • Drummer, O.H. et al., Med. Res. Rev., 1986, 6, 75, (rev, metab)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 1331
  • Bashiardes, C. et al., Tet. Lett., 1987, 28, 5563, (synth)
  • ACE Inhibitors: Current Use and Future Prospects, (ed. Schachter, M.), Martin Dunitz, London, 1995, (book)
  • Martindale, The Extra Pharmacopoeia, 32nd edn., Pharmaceutical Press, 1999, 836
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, MCO750